Torres Denice

SEC Form 4 insider trading activity

Torres Denice has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including SPTX, GKOS, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Nov 4, 2026.

On the most recent filing, Torres Denice is listed as Director at Seaport Therapeutics, Inc. Inside the rolling window, Torres Denice reported 1 open-market purchase totaling $99K in SPTX and no open-market sales.

Companies traded

Other insiders at SPTX

Insider Buying

$99K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
SPTXPurchase$99KNov 4SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Torres Denice made?

Torres Denice has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including SPTX, GKOS since 2026.

Which companies does Torres Denice trade?

Torres Denice has filed SEC Form 4 disclosures for 2 companies, including SPTX, GKOS.

When was Torres Denice's most recent SEC Form 4 filing?

Torres Denice's most recent SEC Form 4 filing on Tracefour is dated Nov 4, 2026.

What is Torres Denice's total buy and sell value in the current window?

Inside the rolling retention window, Torres Denice bought $99K and sold $0 based on SEC Form 4 filings.

What was Torres Denice's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 5,000 SPTX shares on 2026-11-03, worth $99K, per SEC Form 4 filings.